PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry

The term ‘gene doping’ is used to describe the use of any unauthorized gene therapy techniques. We developed a test for five likely candidate genes for equine gene doping: <i>EPO</i>, <i>FST</i>, <i>GH1</i>, <i>IGF1,</i> and <i>ILRN1</i>. T...

Full description

Bibliographic Details
Main Authors: Tessa Wilkin, Natasha A. Hamilton, Adam T. Cawley, Somanath Bhat, Anna Baoutina
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/5/2570
_version_ 1797264430081245184
author Tessa Wilkin
Natasha A. Hamilton
Adam T. Cawley
Somanath Bhat
Anna Baoutina
author_facet Tessa Wilkin
Natasha A. Hamilton
Adam T. Cawley
Somanath Bhat
Anna Baoutina
author_sort Tessa Wilkin
collection DOAJ
description The term ‘gene doping’ is used to describe the use of any unauthorized gene therapy techniques. We developed a test for five likely candidate genes for equine gene doping: <i>EPO</i>, <i>FST</i>, <i>GH1</i>, <i>IGF1,</i> and <i>ILRN1</i>. The test is based on real-time polymerase chain reaction (PCR) and includes separate screening and confirmation assays that detect different unique targets in each transgene. For doping material, we used nonviral (plasmid) and viral (recombinant adeno-associated virus) vectors carrying complementary DNA for the targeted genes; the vectors were accurately quantified by digital PCR. To reduce non-specific amplification from genomic DNA observed in some assays, a restriction digest step was introduced in the PCR protocol prior to cycling to cut the amplifiable targets within the endogenous genes. We made the screening stage of the test simpler and faster by multiplexing PCR assays for four transgenes (EPO, FST, IGF1, and ILRN1), while the GH1 assay is performed in simplex. Both stages of the test reliably detect at least 20 copies of each transgene in a background of genomic DNA equivalent to what is extracted from two milliliters of equine blood. The test protocol was documented and tested with equine blood samples provided by an official doping control authority. The developed tests will form the basis for screening official horseracing samples in Australia.
first_indexed 2024-04-25T00:28:46Z
format Article
id doaj.art-4d6069f11935434b9c98a516b188b534
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-25T00:28:46Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4d6069f11935434b9c98a516b188b5342024-03-12T16:45:28ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-02-01255257010.3390/ijms25052570PCR-Based Equine Gene Doping Test for the Australian Horseracing IndustryTessa Wilkin0Natasha A. Hamilton1Adam T. Cawley2Somanath Bhat3Anna Baoutina4National Measurement Institute, Lindfield, NSW 2070, AustraliaFaculty of Veterinary Science, University of Sydney, Camperdown, NSW 2006, AustraliaAustralian Racing Forensic Laboratory, Racing NSW, Sydney, NSW 2000, AustraliaNational Measurement Institute, Lindfield, NSW 2070, AustraliaNational Measurement Institute, Lindfield, NSW 2070, AustraliaThe term ‘gene doping’ is used to describe the use of any unauthorized gene therapy techniques. We developed a test for five likely candidate genes for equine gene doping: <i>EPO</i>, <i>FST</i>, <i>GH1</i>, <i>IGF1,</i> and <i>ILRN1</i>. The test is based on real-time polymerase chain reaction (PCR) and includes separate screening and confirmation assays that detect different unique targets in each transgene. For doping material, we used nonviral (plasmid) and viral (recombinant adeno-associated virus) vectors carrying complementary DNA for the targeted genes; the vectors were accurately quantified by digital PCR. To reduce non-specific amplification from genomic DNA observed in some assays, a restriction digest step was introduced in the PCR protocol prior to cycling to cut the amplifiable targets within the endogenous genes. We made the screening stage of the test simpler and faster by multiplexing PCR assays for four transgenes (EPO, FST, IGF1, and ILRN1), while the GH1 assay is performed in simplex. Both stages of the test reliably detect at least 20 copies of each transgene in a background of genomic DNA equivalent to what is extracted from two milliliters of equine blood. The test protocol was documented and tested with equine blood samples provided by an official doping control authority. The developed tests will form the basis for screening official horseracing samples in Australia.https://www.mdpi.com/1422-0067/25/5/2570gene dopingreal-time PCRhorseracing
spellingShingle Tessa Wilkin
Natasha A. Hamilton
Adam T. Cawley
Somanath Bhat
Anna Baoutina
PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry
International Journal of Molecular Sciences
gene doping
real-time PCR
horseracing
title PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry
title_full PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry
title_fullStr PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry
title_full_unstemmed PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry
title_short PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry
title_sort pcr based equine gene doping test for the australian horseracing industry
topic gene doping
real-time PCR
horseracing
url https://www.mdpi.com/1422-0067/25/5/2570
work_keys_str_mv AT tessawilkin pcrbasedequinegenedopingtestfortheaustralianhorseracingindustry
AT natashaahamilton pcrbasedequinegenedopingtestfortheaustralianhorseracingindustry
AT adamtcawley pcrbasedequinegenedopingtestfortheaustralianhorseracingindustry
AT somanathbhat pcrbasedequinegenedopingtestfortheaustralianhorseracingindustry
AT annabaoutina pcrbasedequinegenedopingtestfortheaustralianhorseracingindustry